Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiejun Wang

Showing results (221-230 of 229) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 229 results.
Nature Communications|May 27, 2023
Deep learning enables satellite-based monitoring of large populations of terrestrial mammals across heterogeneous landscapeZijing Wu, Ce Zhang, Xiaowei Gu, et al.
Nature Communications|August 12, 2017
Absence of Grail promotes CD8<sup>+</sup> T cell anti-tumour activityCara Haymaker, Yi Yang, Junmei Wang, et al.
Nature Ecology & Evolution|May 25, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|May 14, 2021
Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|October 26, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|July 20, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Nature Communications|March 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trialYang Sun, Hongying Yang, Jing Wang, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 23

Showing results (221-230 of 229) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 229 results.
Nature Communications|May 27, 2023
Deep learning enables satellite-based monitoring of large populations of terrestrial mammals across heterogeneous landscapeZijing Wu, Ce Zhang, Xiaowei Gu, et al.
Nature Communications|August 12, 2017
Absence of Grail promotes CD8<sup>+</sup> T cell anti-tumour activityCara Haymaker, Yi Yang, Junmei Wang, et al.
Nature Ecology & Evolution|May 25, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|May 14, 2021
Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|October 26, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Nature Ecology & Evolution|July 20, 2021
Author Correction: Priority list of biodiversity metrics to observe from spaceAndrew K Skidmore, Nicholas C Coops, Elnaz Neinavaz, et al.
Lancet (London, England)|October 19, 2024
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in ChinaXiaohua Wu, Yang Sun, Hongying Yang, et al.
Nature Communications|March 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trialYang Sun, Hongying Yang, Jing Wang, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 23